These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 28268222

  • 1. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C, Wang W, Jin J, Yu Z, Xin X.
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [Abstract] [Full Text] [Related]

  • 2. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB, Liu XS, Li JQ, Zhao X, Xin D, Yu D.
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM, Gu J, Zhang YS, Wei WJ, Qu N, Wen D, Liao T, Shi RL, Zhang L, Ji QH, Wang Y, Sun GH, Zhao YX, Wang YJ, Yu J, Zhu YX.
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y, Qin H, Cui Y.
    Biochem Biophys Res Commun; 2013 Nov 29; 441(4):958-63. PubMed ID: 24220341
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY, Han C, Zheng LL, Guo MZ.
    Chin Med J (Engl); 2012 Oct 29; 125(19):3526-31. PubMed ID: 23044318
    [Abstract] [Full Text] [Related]

  • 9. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T, Zhang M, Dong Y, Herman JG, van Engeland M, Zhong G, Guo M.
    Discov Med; 2015 Nov 29; 20(111):261-71. PubMed ID: 26645898
    [Abstract] [Full Text] [Related]

  • 10. CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer.
    Zhao W, Chen S, Hou X, Chen G, Zhao Y.
    Cell Physiol Biochem; 2018 Nov 29; 45(4):1590-1602. PubMed ID: 29486482
    [Abstract] [Full Text] [Related]

  • 11. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S.
    Cancer Biomark; 2018 Nov 29; 22(2):217-226. PubMed ID: 29630517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
    Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
    Surgery; 2006 Dec 29; 140(6):899-905; discussion 905-6. PubMed ID: 17188136
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F, Zhang Q, Chen W, Zhang H, Lu G, Chen J, Qiu C.
    J Cell Biochem; 2019 Jun 29; 120(6):10380-10390. PubMed ID: 30609134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C, Song H, Sun X, Li D, Song J, Hua K, Fang L.
    Oncol Rep; 2015 Jul 29; 34(1):211-20. PubMed ID: 26063221
    [Abstract] [Full Text] [Related]

  • 18. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M, Uddin S, Hussain AR, Alyan A, Jehan Z, Al-Dayel F, Al-Nuaim A, Al-Sobhi S, Amin T, Bavi P, Al-Kuraya KS.
    J Clin Endocrinol Metab; 2012 Jan 29; 97(1):E1-E13. PubMed ID: 22049175
    [Abstract] [Full Text] [Related]

  • 19. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
    Xu J, Cai J, Jin X, Yang J, Shen Q, Ding X, Liang Y.
    Oncol Rep; 2015 Sep 29; 34(3):1424-30. PubMed ID: 26133772
    [Abstract] [Full Text] [Related]

  • 20. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
    Schagdarsurengin U, Richter AM, Wöhler C, Dammann RH.
    Epigenetics; 2009 Nov 16; 4(8):571-6. PubMed ID: 19934646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.